Page address:
http://www.burrillreport.com/printer_topic-business.html
back to normal view »
REVIEW / PREVIEW:
G. Steven Burrill Issues Annual Predictions for Biotech Industry
Focus to shift from promise to execution in 2015
As the end of 2014 approaches, a year of unprecedented financial activity and dealmaking for the biotechnology industry, biotech visionary G. Steven Burrill issued his annual predictions for the life sciences in the new year.
Read More
Finance
Life Sciences M&A; Activity Sets Annual Record with $8.3B Roche Agreement to buy Intermune, Burrill Media Reports
Press Release
Read More.
Dealmaking
Sanofi Licenses Rights to MannKind’s Afrezza for Up to $925M
After many years of struggling, biotech lands marketing partner for inhaled insulin.
Read More.
Dealmaking
Cerner Buys Siemens Health Services for $1.3B
Deal creates scale for future innovation, moving company beyond electronic medical records.
Read More.
Dealmaking
Meda to Acquire Rottapharm for $3.1B
Deal creates a European specialty pharmaceutical powerhouse.
Read More.
Drug Development
BioMarin Sells Priority Review Voucher for $67.5 Million
Deal puts a dollar value on the FDA incentive program for rare pediatric conditions.
Read More.
On the Move
Gilead Sciences on a Roll
Biotech reports huge Q2 earnings jump, gains FDA approval and EU nod for new cancer drug.
Read More.
Drug Development
Drugmakers Share Shelved Compounds with UK Researchers
MRC researchers will study them to help understand the biology of disease, and possibly to repurpose them.
Read More.
Dealmaking
AbbVie and Shire Agree to $54B Union
Chicago-based AbbVie will move headquarters to U.K. in biggest tax inversion deal to date.
Read More.
Business Strategy
Salix to Merge with Cosmo Tech in Tax Inversion Deal
Transaction broadens Salix’s GI offerings and gives it tax advantages of being headquartered in Ireland.
Read More.
Drug Development
Racing to the $1 Trillion Sales Mark
Podcast: July 7, 2014
Read More.
Business Strategy
Unlocking Value
Podcast: June 30, 2014
Read More.
Dealmaking
Bionomics and Merck Partner in Deal Worth Up to $526M
Pharma will fund development of compounds to treat the cognitive dysfunction in neurodegenerative diseases.
Read More.
Business Strategy
Monoclonal Antibodies Going to the Dogs (and Cats)
Podcast: June 23, 2014
Read More.
Dealmaking
Medtronic to Buy Covidien for $42.9 Billion
Medical device maker’s inversion deal will move its corporate headquarters to Ireland.
Read More.
BIO International Convention
San Diego Steps into the Biotech Spotlight
Podcast: June 16, 2014
Read More.
